Company
Enclear Therapies
Extending the lives of patients suffering from CNS disease
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- encleartherapies.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our mission is to improve and extend the lives of patients suffering from central nervous system (CNS) disorders such as neurodegenerative diseases and CNS malignancies.
Funding snapshot
- Total raised
- $10MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series A, $10M2020-02-18
Funding rounds
- Round, 2024
- $718K2024-02-22, SEC form D sold, 8 investors
- Series A
- $10M2020-02-18, Company stated
Products
- Hardware
- EnTrega CSF Platform
Loading relationship preview